• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Unocal

Unocal

Fidelity Advisor Asset Manager® 20% A FTAWX 2 Star

Last Price$13.25Day Change (%)0.00%
Open Price$13.25Day Change ($)0.00
Day Range13.25–13.2552-Week Range12.37–13.27

As of Tue 08/30/2016 | USD

  1. All
  2. 3rd Party
  3. Investing
  1. Cell Medica and UCL Collaborate to Develop Modified T Cell Receptor Products for the Treatment of Cancer

    Cell Medica and UCL Collaborate to Develop Modified T Cell Receptor Products for the Treatment of Cancer

  2. Autifony Therapeutics successfully completes Phase I study of AUT00206, a first-in-class Kv3 modulator for schizophrenia

    Autifony Therapeutics successfully completes Phase I study of AUT00206, a first-in-class Kv3 modulator for schizophrenia

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.